ARCA Biopharma Shares Drop 13% After South America Approval for Covid-19 Treatment

Retrieved on: 2021-07-13 17:37:21

Tags for this article:

Click the tags to see associated articles and topics

ARCA Biopharma Shares Drop 13% After South America Approval for Covid-19 Treatment. View article details on hiswai:

Excerpt

By Chris Wack. ARCA Biopharma Inc. shares were down 13% to $3.22 after the company said it received approval from regulatory authorities in ...

Article found on: www.marketwatch.com